Physician profile
Nehal Modha
NPI 1508495714
$5,765.77
in general payments reported to CMS, 2019-2025
13 companies · $809 in 2025
The $809 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $170 · 2021: $636 · 2022: $484 · 2023: $1,714 · 2024: $1,953 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,859 · Travel and Lodging: $1,532 · Education: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,859.38 |
| Travel and Lodging | $1,532.01 |
| Education | $1,084.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,377.65 | 2022-2024 | Variax, Augment Injectable, Citrefix |
| Biotissue Holdings INC. | $603.78 | 2021-2023 | |
| Voom Medical Devices, INC. | $520.70 | 2025 | Revcon Instrument Kit, Sterile |
| Horizon Therapeutics Plc | $230.80 | 2021 | |
| Amniox Medical, INC. | $169.61 | 2020 | |
| Fusion Orthopedics USA, LLC | $150.00 | 2025 | |
| Bone Support INC. | $148.09 | 2024 | Ceramentbone Void Filler, Cerament G |
| Zimmer Biomet Holdings, INC. | $138.31 | 2025 | Stratum Foot Plating System |
| Heron Therapeutics, INC. | $124.98 | 2021 | |
| Nevro Corp. | $121.93 | 2022 | |
| Organogenesis INC. | $85.82 | 2024 | |
| Smith+Nephew, INC. | $74.30 | 2023 | Evos Mini, Cadence, Panta 2 |
| Paragon 28, INC. | $19.80 | 2024 | Silverback |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nehal Modha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.